Biolife Sciences (Biolife Sciences) Interest Expense : $0.00 Mil (TTM As of May. 2008)

View and export this data going back to 2005. Start your Free Trial

What is Biolife Sciences Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Biolife Sciences's interest expense for the three months ended in May. 2008 was $ 0.00 Mil. Its interest expense for the trailing twelve months (TTM) ended in May. 2008 was $0.00 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Biolife Sciences's Operating Income for the three months ended in May. 2008 was $ 0.08 Mil. Biolife Sciences's Interest Expense for the three months ended in May. 2008 was $ 0.00 Mil. GuruFocus does not calculate Biolife Sciences's interest coverage with the available data. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Biolife Sciences Interest Expense Historical Data

The historical data trend for Biolife Sciences's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biolife Sciences Interest Expense Chart

Biolife Sciences Annual Data

Trend

Nov04

Nov05

Nov06

Nov07

Interest Expense

Biolife Sciences Quarterly Data
	Nov04	Feb05	May05	Aug05	Nov05	Feb06	May06	Aug06	Nov06	Feb07	May07	Aug07	Nov07	Feb08	May08
Interest Expense	Get a 7-Day Free Trial										-	-	-	-	-

Biolife Sciences Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in May. 2008 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

Biolife Sciences (OTCPK:BLFE) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Biolife Sciences's Interest Expense for the three months ended in May. 2008 was $0.00 Mil. Its Operating Income for the three months ended in May. 2008 was $0.08 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in May. 2008 was $0.42 Mil.

Biolife Sciences's Interest Coverage for the quarter that ended in May. 2008 is calculated as

GuruFocus does not calculate Biolife Sciences's interest coverage with the available data.

The higher the ratio, the stronger the company's financial strength is.

Biolife Sciences (Biolife Sciences) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Biolife Sciences Inc (OTCPK:BLFE) » Definitions » Interest Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

2831 Street Rose Parkway, No. 200, Henderson, NV, USA, 89052

Website

https://www.biolifesciences.com

Biolife Sciences Inc is a commercialization accelerator, licensor and developer of innovative and disruptive technologies for the healthcare, beauty and food and beverage industry sectors. The company's technologies include antimicrobial copper air filters and copper-infused textiles. Its revenues are primarily generated from the sale of sanitation products.

Executives

Arthur Viola

director, 10 percent owner, officer: CEO

Biolife Sciences (Biolife Sciences) Headlines

From GuruFocus

Rhino Novi Announces Name Change and New CEO

By Marketwired Marketwired • 09-15-2020